JP2022510690A5 - - Google Patents
Info
- Publication number
- JP2022510690A5 JP2022510690A5 JP2021532071A JP2021532071A JP2022510690A5 JP 2022510690 A5 JP2022510690 A5 JP 2022510690A5 JP 2021532071 A JP2021532071 A JP 2021532071A JP 2021532071 A JP2021532071 A JP 2021532071A JP 2022510690 A5 JP2022510690 A5 JP 2022510690A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- group
- aryl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024199809A JP2025028061A (ja) | 2018-12-05 | 2024-11-15 | 肝障害の処置のための組成物及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862775799P | 2018-12-05 | 2018-12-05 | |
| US62/775,799 | 2018-12-05 | ||
| US201962821303P | 2019-03-20 | 2019-03-20 | |
| US62/821,303 | 2019-03-20 | ||
| PCT/US2019/064548 WO2020117987A1 (en) | 2018-12-05 | 2019-12-04 | Compositions and methods for the treatment of liver disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199809A Division JP2025028061A (ja) | 2018-12-05 | 2024-11-15 | 肝障害の処置のための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022510690A JP2022510690A (ja) | 2022-01-27 |
| JP2022510690A5 true JP2022510690A5 (https=) | 2022-12-13 |
Family
ID=70974003
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532071A Pending JP2022510690A (ja) | 2018-12-05 | 2019-12-04 | 肝障害の処置のための組成物及び方法 |
| JP2024199809A Pending JP2025028061A (ja) | 2018-12-05 | 2024-11-15 | 肝障害の処置のための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199809A Pending JP2025028061A (ja) | 2018-12-05 | 2024-11-15 | 肝障害の処置のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220016136A1 (https=) |
| EP (1) | EP3890748A4 (https=) |
| JP (2) | JP2022510690A (https=) |
| KR (1) | KR20210099612A (https=) |
| CN (1) | CN113365637A (https=) |
| AU (2) | AU2019394947B2 (https=) |
| BR (1) | BR112021010916A2 (https=) |
| CA (1) | CA3121620A1 (https=) |
| MX (5) | MX2021006575A (https=) |
| WO (1) | WO2020117987A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007014502A (es) | 2005-05-26 | 2008-02-07 | Metabasis Therapeutics Inc | Tiromimeticos para el tratamiento de enfermedades del higado graso. |
| JP2020500199A (ja) | 2016-11-21 | 2020-01-09 | バイキング・セラピューティクス・インコーポレイテッド | グリコーゲン蓄積症の治療方法 |
| AU2018280118B2 (en) | 2017-06-05 | 2021-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| ES3053674T3 (en) | 2018-03-22 | 2026-01-23 | Viking Therapeutics Inc | Crystalline forms and methods of producing crystalline forms of a compound |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| CN112707892A (zh) * | 2019-10-24 | 2021-04-27 | 苏州泽璟生物制药股份有限公司 | 哒嗪酮或哒嗪类化合物及其衍生物和药物组合物 |
| HRP20241159T1 (hr) | 2020-02-07 | 2024-12-06 | Gasherbrum Bio, Inc. | Heterociklički agonisti za glp-1 |
| US11752161B2 (en) | 2020-03-27 | 2023-09-12 | Gannex Pharma Co., Ltd. | Pharmaceutical compositions, method of making and method of using thereof |
| TW202206429A (zh) | 2020-04-29 | 2022-02-16 | 美商迦舒布魯姆生物有限公司 | 雜環ｇｌｐ—１促效劑 |
| US20230226038A1 (en) * | 2020-06-09 | 2023-07-20 | Viking Therapeutics, Inc. | Compositions and methods for the treatment of liver disorders |
| CN113831337B (zh) * | 2020-06-24 | 2023-03-24 | 广州市恒诺康医药科技有限公司 | Glp-1受体激动剂及其药物组合物和用途 |
| CN115093404B (zh) * | 2020-07-17 | 2024-06-21 | 瀚海新拓(杭州)生物医药有限公司 | 苯并五元杂环磺酰胺类化合物、其制备方法、药物组合物及应用 |
| JP2023537501A (ja) | 2020-08-06 | 2023-09-01 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環ｇｌｐ－１アゴニスト |
| PT4408840T (pt) | 2021-09-27 | 2025-10-07 | Terns Pharmaceuticals Inc | Ácidos benzimidazolocarboxílicos como agonistas de glp-1r |
| JP2025509281A (ja) | 2022-03-09 | 2025-04-11 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環式ｇｌｐ－１アゴニスト |
| US20250250269A1 (en) | 2022-04-14 | 2025-08-07 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| TW202435857A (zh) | 2022-12-15 | 2024-09-16 | 美商迦舒布魯姆生物有限公司 | 具有glp-1促效劑活性之化合物之鹽及固體形式 |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
| WO2025193816A1 (en) * | 2024-03-14 | 2025-09-18 | Viking Therapeutics, Inc. | Pharmaceutical compositions and methods for the treatment of metabolic and liver disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1882327A (zh) * | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| MX2007014502A (es) * | 2005-05-26 | 2008-02-07 | Metabasis Therapeutics Inc | Tiromimeticos para el tratamiento de enfermedades del higado graso. |
| CA2760096C (en) * | 2009-04-27 | 2018-10-30 | Immuron Limited | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder. |
| WO2011038207A1 (en) * | 2009-09-25 | 2011-03-31 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyroid hormone receptor agonists and methods of use |
| AU2013255103B2 (en) * | 2012-05-02 | 2016-09-29 | Syntara Limited | Substituted 3-haloallylamine inhibitors of SSAO and uses thereof |
| JP7266531B2 (ja) * | 2017-04-18 | 2023-04-28 | ジェンフィ | エラフィブラノール又はその誘導体と抗ｎａｓｈ剤、抗線維化剤又は抗胆汁うっ滞性剤の組合せ |
| AU2018280118B2 (en) * | 2017-06-05 | 2021-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| US20230226038A1 (en) * | 2020-06-09 | 2023-07-20 | Viking Therapeutics, Inc. | Compositions and methods for the treatment of liver disorders |
-
2019
- 2019-12-04 CN CN201980091024.3A patent/CN113365637A/zh active Pending
- 2019-12-04 AU AU2019394947A patent/AU2019394947B2/en active Active
- 2019-12-04 EP EP19893549.6A patent/EP3890748A4/en active Pending
- 2019-12-04 JP JP2021532071A patent/JP2022510690A/ja active Pending
- 2019-12-04 CA CA3121620A patent/CA3121620A1/en active Pending
- 2019-12-04 BR BR112021010916-1A patent/BR112021010916A2/pt unknown
- 2019-12-04 KR KR1020217020331A patent/KR20210099612A/ko active Pending
- 2019-12-04 US US17/311,014 patent/US20220016136A1/en active Pending
- 2019-12-04 WO PCT/US2019/064548 patent/WO2020117987A1/en not_active Ceased
- 2019-12-04 MX MX2021006575A patent/MX2021006575A/es unknown
-
2021
- 2021-06-03 MX MX2024001205A patent/MX2024001205A/es unknown
- 2021-06-03 MX MX2024001203A patent/MX2024001203A/es unknown
- 2021-06-03 MX MX2024001201A patent/MX2024001201A/es unknown
- 2021-06-03 MX MX2024001204A patent/MX2024001204A/es unknown
-
2024
- 2024-11-15 JP JP2024199809A patent/JP2025028061A/ja active Pending
-
2025
- 2025-08-22 AU AU2025220854A patent/AU2025220854A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022510690A5 (https=) | ||
| JP7604666B2 (ja) | 代謝及び肝臓障害の処置のための組成物及び方法 | |
| ES2836973T3 (es) | Derivados de ácido carboxílico que comprenden cuatro ciclos que actúan como moduladores de receptor GLP-1 para la terapia de enfermedades tales como la diabetes | |
| RU2569063C2 (ru) | Конъюгаты жирных кислот и ниацина и их применение | |
| ES2525429T3 (es) | Inhibidores de la proteína tirosina fosfatasa humana y métodos de uso | |
| ES2397664T3 (es) | Derivados de glucopiranósilo que contienen tienilo como antidiabéticos | |
| US8188125B2 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
| JP4643760B2 (ja) | Ｄｐｐ−ｉｖ阻害薬と他の糖尿病治療薬との併用又は組み合せからなる医薬 | |
| US20130190327A1 (en) | Bis-fatty acid conjugates and their uses | |
| WO2009038204A1 (ja) | 新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするｇタンパク質共役型レセプター作動剤 | |
| EA021174B1 (ru) | Применение ингибиторов дипептидилпептидазы | |
| KR20110013411A (ko) | (ｆ-19)-표지된 ｌ-글루탐산 및 ｌ-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법 | |
| US20080234337A1 (en) | Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist | |
| JP2024095711A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| US20090074844A1 (en) | Trenadermal absorption preparation | |
| KR20250041009A (ko) | 대사 및 간 장애 치료를 위한 조성물 및 방법 | |
| JP5014978B2 (ja) | ヘテロ６員環化合物及びその用途 | |
| ES2202449T3 (es) | Inhibidor de edema cerebral. | |
| JP7812338B2 (ja) | Ｇｌｐ受容体アゴニスト | |
| US20040152753A1 (en) | Methods of use for novel sulfur containing organic nitrate compounds | |
| JP7661969B2 (ja) | １，４，５，６－テトラヒドロピリミジン－２－アミン誘導体 | |
| JP2023553989A5 (https=) | ||
| US7129256B2 (en) | Antiparkinsonism drugs | |
| ES2890924T3 (es) | Derivados de imidazol para el tratamiento de la hipertensión y/o la fibrosis | |
| JP2009513606A (ja) | β−３受容体アゴニストとして使うためのベンゾイミダゾール誘導体 |